Abstract
The treatment of non-infectious uveitis is often a challenging experience for both the patient and the treating physician. The use of traditional forms of treatment is restricted by limited effectiveness and considerable side effects. This review examines the current trends in therapy and the emerging new classes of therapeutic agents used in the treatment of non-infectious uveitis. It then examines some of the newer approaches apparent from recent patenting over the past four years and assesses their likely future significance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
